OpenBilldrug price receipt

NADAC week of 2026-10-14

GUAIFENESIN-PSE ER 1200-120 MG

For 30 tablets

Pharmacies pay

$12.70 filed

30 × $0.42347 per EA

CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17

Medicare

We don’t know yet

No Medicare reference price. Part D: OpenBill did not match this NDC to a usable Medicare Part D spending row. Either Part D has none for it, or the rows that share its name could not safely be tied to it (for example, they mix units, routes or release forms, or the drug is sold over the counter, which Part D does not cover). Part B: This NDC is not in the current quarter’s Medicare Part B NDC-HCPCS crosswalk, so it has no Part B payment limit.


The spread

We don’t know yet

There is no Medicare figure to compare with, so there is no spread.

Cost-plus estimate

$19.61 estimated

$12.70 + $1.91 (15%) + $5.00 fee per fill = $19.61

This is a model, not a price any pharmacy quoted. Shipping is not included. How it is worked out

OpenBill calculation · nadac-national-average-drug-acquisition-cost-20261014.csv · NADAC eff. 2026-09-23 (file of 2026-10-14, retrieved 2026-10-17)

Open the interactive card Change the quantity, type what you were charged, and see every record in full.

What it is

GUAIFENESIN-PSE ER 1200-120 MG is how the CMS NADAC file names this product. The FDA NDC Directory lists it as guaifenesin and pseudoephedrine hcl.

FDA gives its dosage form as tablet, extended release and its route as oral.

The labeler, the company named on the label, is Dr. Reddys Laboratories Limited.

FDA lists it under 2 Established Pharmacologic Classes: alpha-Adrenergic Agonist and Expectorant.

The NADAC file of 2026-10-14 prices it under one NDC (National Drug Code), 55111-0799-24.

NADAC classes it as a generic drug (rate-setting class G), and marks it as sold over the counter.

What pharmacies pay

Pharmacies pay $12.70 for 30 tablets (30 × $0.42347 per EA, rounded to the cent), by the CMS NADAC file of 2026-10-14; that price took effect on 2026-09-23. That is what pharmacies pay their suppliers, not what they charge you.

NADAC’s explanation code for it: 1, calculated from the most recently completed pharmacy survey.

The NDC

Other strengths, forms and brands

2 other products in the NADAC file share the FDA nonproprietary name guaifenesin and pseudoephedrine hcl with GUAIFENESIN-PSE ER 1200-120 MG.

ProductPharmacies pay per unitMedicare per unit
FT MUCUS RELIEF D ER 600-60 MG
generic · tablet, extended release / tablet, multilayer, extended release
$0.38412 per EA filed
eff. 2026-09-23
We don’t know yet
GUAIFENESIN-PSE ER 600-60 MG
generic · tablet, extended release
$0.38412 per EA filed
eff. 2026-09-23
We don’t know yet
GUAIFENESIN-PSE ER 1200-120 MG this page
generic · tablet, extended release
$0.42347 per EA filed
eff. 2026-09-23
We don’t know yet

CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17

Compared with its class

Its NADAC price is $0.42347 per EA filed.

Of the 59 other products in FDA’s alpha-Adrenergic Agonist class priced per EA, 31 have a higher middle NADAC price and 25 a lower one; 3 have the same. The one in the middle is GNP FEXOFENADINE-PSE ER 60-120, at $0.48321 per EA filed (eff. 2026-09-23).

Of the 68 other products in FDA’s Expectorant class priced per EA, 14 have a higher middle NADAC price and 51 a lower one; 3 have the same. The one in the middle is QC MUCUS RLF COLD-FLU-THRT CPT, at $0.13211 per EA filed (eff. 2026-09-23).

Prices are compared per unit, whatever the strength or dose, and a class is not a list of substitutes.

CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17

What Medicare paid

We don’t know yet; the card above says why.

What to ask at the counter

None of these figures is your price: what you pay depends on your pharmacy, your insurance, coupons and discounts.